Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Highlights • Amongst the gastrointestinal manifestations experienced by COVID-19 patients, those commonly noted are diarrhea, anorexia, nausea, vomiting, and abdominal pain – which can be present even in the absence of respiratory symptoms.• Hepatic injury is evident in some patients, the degree of which at times can mirror severity of disease; pancreatic injury has been noted as well.• SARS-CoV-2 RNA has been found in fecal samples even after viral RNA in respiratory samples clears, raising concern for gastrointestinal viral replication and potential for fecal-oral transmission.• While no definitive treatment for COVID-19 exists, mainstay remains supportive including oxygen and mechanical ventilation; at this time, gastrointestinal manifestations are largely managed symptomatically as well.• The potential for fecal-oral spread of infectious virions may warrant additional precautions and patient education about proper hand hygiene, social distancing, and understanding the risk for close contacts and re-infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735 · cited 3×
“SARS-CoV-2 is an enveloped, non-segmented, positive-sense RNA virus responsible for the 2019 coronavirus disease (COVID-19) pandemic 1, 2 .”
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
Evidence for gastrointestinal infection of SARS-CoV-2
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.055 · Cited by 2,836
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission
Tian, Y., Rong, L., Nian, W., & He, Y. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15731 · Cited by 832 · cited 2×
“Furthermore, other symptoms noted were anorexia (39.9%-50.2%), vomiting (3.6%-66.7%), nausea (1%-29.4%), abdominal pain (2.2%-6.0%), and gastrointestinal bleeding (4%-13.7%) 12 .”
InfluentialZhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., Cui, X., Xiao, J., Meng, T., Zhou, W., et al. (2020) · doi:10.1101/2020.01.30.927806 · Cited by 658 · cited 1×
“Absorptive enterocytes may be infected and destroyed by SARS-CoV-2, potentially leading to malabsorption, unbalanced intestinal secretion, and an activated enteric nervous system resulting in symptoms like diarrhea 15 .”
Cited by
Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., et al. (2021) · Advanced Science · doi:10.1002/advs.202101222 · Cited by 88
Metadata
- Authors
- Patel, K. P., Patel, P. A., Vunnam, R. R., Hewlett, A. T., Jain, R., Jing, R., & Vunnam, S. R.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 128
- Pages
- 104386
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W3023459163
- Cited by
- 211
- References
- 9
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.